432 related articles for article (PubMed ID: 25278160)
1. Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.
Song X; Pang L; Feng Y; Fan X; Li X; Zhang W; Gao J; Zhang J; Nemani K; Zhang H; Lv L
Behav Brain Funct; 2014 Oct; 10(1):35. PubMed ID: 25278160
[TBL] [Abstract][Full Text] [Related]
2. Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
Shing EC; Tiwari AK; Brandl EJ; Zai CC; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
Neuropsychobiology; 2014; 69(1):59-63. PubMed ID: 24481458
[TBL] [Abstract][Full Text] [Related]
3. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.
Perez-Iglesias R; Mata I; Amado JA; Berja A; Garcia-Unzueta MT; Martínez García O; Arranz MJ; Vazquez-Barquero JL; Crespo-Facorro B
J Clin Psychopharmacol; 2010 Dec; 30(6):661-6. PubMed ID: 21105276
[TBL] [Abstract][Full Text] [Related]
4. Correlations between FTO Gene Polymorphisms and TSH Level in Uyghur Chinese Patients with Type 2 Diabetes.
Wang L; Yi Q; Yao H; He L; Fang B; Xu W; Su Y; Liu J; Ma Q
Biomed Res Int; 2021; 2021():6646750. PubMed ID: 34258276
[TBL] [Abstract][Full Text] [Related]
5. Association of the FTO (rs9939609) and MC4R (rs17782313) gene polymorphisms with maternal body weight during pregnancy.
Martins MC; Trujillo J; Farias DR; Struchiner CJ; Kac G
Nutrition; 2016; 32(11-12):1223-30. PubMed ID: 27377581
[TBL] [Abstract][Full Text] [Related]
6. Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly.
Franczak A; Kolačkov K; Jawiarczyk-Przybyłowska A; Bolanowski M
Pituitary; 2018 Feb; 21(1):10-15. PubMed ID: 28913579
[TBL] [Abstract][Full Text] [Related]
7. Genetic association between antipsychotic induced weight gain and FTO gene in a Sri Lankan population.
de Silva VA; Muneeswaran K; Ratnatunga SS; Ranwala I; Gamage S; Hanwella R; Wijeyaratne CN; Chandrasekharan NV
Ceylon Med J; 2019 Jun; 64(2):40-45. PubMed ID: 31455065
[TBL] [Abstract][Full Text] [Related]
8. Fat Mass and Obesity-Related Gene Variants rs9939609 and rs7185735 are Associated with Second-Generation Antipsychotic-Induced Weight Gain.
Schröder C; Czerwensky F; Leucht S; Steimer W
Pharmacopsychiatry; 2019 Jan; 52(1):16-23. PubMed ID: 29334686
[TBL] [Abstract][Full Text] [Related]
9. Differences in body mass index according to fat mass- and obesity-associated (FTO) genotype in Mexican patients with bipolar disorder.
Díaz-Anzaldúa A; Ocampo-Mendoza Y; Hernández-Lagunas JO; Díaz-Madrid FA; Romo-Nava F; Juárez-García F; Ortega-Ortiz H; Díaz-Anzaldúa A; Gutiérrez-Mora D; Becerra-Palars C; Berlanga-Cisneros C
Bipolar Disord; 2015 Sep; 17(6):662-9. PubMed ID: 26529281
[TBL] [Abstract][Full Text] [Related]
10. The A-allele of the common FTO gene variant rs9939609 complicates weight maintenance in severe obese patients.
Woehning A; Schultz JH; Roeder E; Moeltner A; Isermann B; Nawroth PP; Wolfrum C; Rudofsky G
Int J Obes (Lond); 2013 Jan; 37(1):135-9. PubMed ID: 22310469
[TBL] [Abstract][Full Text] [Related]
11.
Gu Z; Bi Y; Yuan F; Wang R; Li D; Wang J; Hu X; He G; Zhang L; Liu BC
Clin Interv Aging; 2020; 15():1333-1341. PubMed ID: 32848374
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.
Scuteri A; Sanna S; Chen WM; Uda M; Albai G; Strait J; Najjar S; Nagaraja R; Orrú M; Usala G; Dei M; Lai S; Maschio A; Busonero F; Mulas A; Ehret GB; Fink AA; Weder AB; Cooper RS; Galan P; Chakravarti A; Schlessinger D; Cao A; Lakatta E; Abecasis GR
PLoS Genet; 2007 Jul; 3(7):e115. PubMed ID: 17658951
[TBL] [Abstract][Full Text] [Related]
13. 'Fat mass and obesity associated' gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents.
Müller TD; Hinney A; Scherag A; Nguyen TT; Schreiner F; Schäfer H; Hebebrand J; Roth CL; Reinehr T
BMC Med Genet; 2008 Sep; 9():85. PubMed ID: 18799002
[TBL] [Abstract][Full Text] [Related]
14. Association of FTO polymorphisms with obesity and metabolic parameters in Han Chinese adolescents.
Wu J; Xu J; Zhang Z; Ren J; Li Y; Wang J; Cao Y; Rong F; Zhao R; Huang X; Du J
PLoS One; 2014; 9(6):e98984. PubMed ID: 24911064
[TBL] [Abstract][Full Text] [Related]
15. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis.
Wojciechowski P; Lipowska A; Rys P; Ewens KG; Franks S; Tan S; Lerchbaum E; Vcelak J; Attaoua R; Straczkowski M; Azziz R; Barber TM; Hinney A; Obermayer-Pietsch B; Lukasova P; Bendlova B; Grigorescu F; Kowalska I; Goodarzi MO; ; Strauss JF; McCarthy MI; Malecki MT
Diabetologia; 2012 Oct; 55(10):2636-2645. PubMed ID: 22801903
[TBL] [Abstract][Full Text] [Related]
16. Association of FTO polymorphisms with early age of obesity in obese Italian subjects.
Sentinelli F; Incani M; Coccia F; Capoccia D; Cambuli VM; Romeo S; Cossu E; Cavallo MG; Leonetti F; Baroni MG
Exp Diabetes Res; 2012; 2012():872176. PubMed ID: 22454631
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the FTO gene polymorphisms (rs1421085, rs17817449 and rs9939609) in exercise-trained men and women: the effects of a 4-week hypocaloric diet.
Antonio J; Knafo S; Kenyon M; Ali A; Carson C; Ellerbroek A; Weaver C; Roberts J; Peacock CA; Tartar JL
J Int Soc Sports Nutr; 2019 Sep; 16(1):36. PubMed ID: 31477138
[TBL] [Abstract][Full Text] [Related]
18. The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients.
Reynolds GP; Yevtushenko OO; Gordon S; Arranz B; San L; Cooper SJ
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1421-5. PubMed ID: 23236985
[TBL] [Abstract][Full Text] [Related]
19. Minor alleles of
Zhang Y; Chen L; Zhu J; Liu H; Xu L; Wu Y; He C; Song Y
Front Endocrinol (Lausanne); 2023; 14():1249070. PubMed ID: 38161971
[TBL] [Abstract][Full Text] [Related]
20. DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.
Lencz T; Robinson DG; Napolitano B; Sevy S; Kane JM; Goldman D; Malhotra AK
Pharmacogenet Genomics; 2010 Sep; 20(9):569-72. PubMed ID: 20664489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
